Blog
0
Metastatic Hormone-Sensitive Prostate Cancer Treatment Options
0

Transcript:For patients with metastatic hormone-sensitive prostate cancer, what are the treatment options?Alicia Morgans, M.D., MPH: Metastatic ...

0
Chemo Shortage Improved But Remains an ‘Ongoing Crisis’
0

A recent survey of National Comprehensive Cancer Network (NCCN)-designated cancer centers revealed that 86% of surveyed institutions are experiencing a ...

0
Sexual Activity May Reduce Long-Term Side Effects After Cervical Cancer
0

Engaging in sexual activity or vaginal dilation may lower the risk of developing long-term side effects for patients with cervical cancer, according to ...

0
Selecting Appropriate Treatments for Patients With Advanced RCC
0

Expert perspectives on the decision-making process for selecting frontline systemic therapy for patients with advanced renal cell carcinoma.

0
Exercise Can Help Empower Patients With Cancer
0

Research shows that exercise can reduce the rate of cancer recurrence, from 20% to 60% less, according to Jen Miramontes, founder of Cancer Champions, a ...

0
FDA Approves Braftovi and Mektovi for Some Patients with Metastatic NSCLC
0

The Food and Drug Administration (FDA) has approved Braftovi (encorafenib) with Mektovi (binimetinib) for the treatment of adult patients with metastatic ...

0
Novel Drug-Immunotherapy Combo Boosts Survival in Rare Prostate Cancer
0

The addition of the novel drug, BXCL701 to the immunotherapy agent, Keytruda (pembrolizumab) tended to improve survival over Keytruda alone in patients with ...

0
Patients with Advanced Gastric, Esophageal Cancers Maintain Quality of Life with Opdivo
0

Patients with advanced/metastatic non–human epidermal growth factor receptor 2 (HER2)-positive gastric/gastroesophageal junction cancer (GC/GEJC) or ...

0
“Seeing those results for the first time made my whole career seem worthwhile” – Peter Sasieni wins Don Listwin Award – Cancer Research UK
0

What advice do you have for researchers interested in making meaningful contributions to the field of cancer prevention and early detection? Dream big. ...

0
I Have Lynch syndrome —The Evolution From Patient To Advocate
0

My initial foray into advocacy was born out of the need to shed light on the often-overlooked drawbacks of an oophorectomy I underwent at a young age. This ...

0
Antidepressants After Diagnosis of Liver Cancer May Lower Mortality Rates
0

The use of antidepressant medication after receiving a diagnosis of hepatocellular carcinoma (HCC) may be associated with lower overall and cancer-specific ...

0
Chemotherapy Resistance for Some Patients With Ovarian Cancer May Have Genetic Cause
0

A certain gene may be the cause of chemotherapy resistance in some patients with ovarian cancer, according to a recent study.In a study published in Genes ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart